CBLL vs PMI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PMI Captures Institutional Edge (3โ1 Pillars ยท 4โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Growth & Margin, Momentum & Technical while CBLL counters with relative strength in Options & Structure. Fundamentally, CBLL trades at N/M Forward P/E with -69.8% operating margin (+29.9% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, CBLL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CBLL | PMI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $995.3M | $17.1M | Larger Scale | CBLL |
| Trailing P/E Ratio Valuation | N/M | 2.9x | Lower Multiple | PMI |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +29.9% | +38.6% | Higher Growth | PMI |
| Operating Margin (TTM) Profitability | -69.8% | -248.1% | Higher Margin | CBLL |
| Net Profit Margin Profitability | -68.0% | 0.0% | Higher Margin | PMI |
| Return on Equity (ROE) Capital Efficiency | -52.5% | 0.0% | Higher ROE | PMI |
| 52-Week Range Position Momentum | 81% ($13โ$29) | 34% ($0โ$18) | Stronger Trend | CBLL |
| Beta / 30D Volatility Risk Regime | 1.08ฮฒ ยท 41% Vol | 54.06ฮฒ ยท 134% Vol | Lower Realized Risk | CBLL |
| Unified Institutional Score Composite Signal | 59.7 / 100 (HOLD) | 48.4 / 100 (HOLD) | Higher Composite | CBLL |